Stable Coronary Artery Disease Patients: Different Practice Patterns in Everyday Clinical Situations

por Berezin, Alexander E.
Publicado 2015

Prognostication in Different Heart Failure Phenotypes: The Role of Circulating Biomarkers

por Berezin, Alexander E.
Publicado 2016

Analysis of Various Subsets of Circulating Mononuclear Cells in Asymptomatic Coronary Artery Disease

por Berezin, Alexander E., Kremzer, Alexander A.
Publicado 2013

Predictive value of circulating osteonectin in patients with ischemic symptomatic chronic heart failure

por Berezin, Alexander E., Kremzer, Alexander A.
Publicado 2015

Extracellular Endothelial Cell-Derived Vesicles: Emerging Role in Cardiac and Vascular Remodeling in Heart Failure

por Berezin, Alexander E., Berezin, Alexander A.
Publicado 2020

Circulating Cardiac Biomarkers in Diabetes Mellitus: A New Dawn for Risk Stratification—A Narrative Review

por Berezin, Alexander E., Berezin, Alexander A.
Publicado 2020

Adverse Cardiac Remodelling after Acute Myocardial Infarction: Old and New Biomarkers

por Berezin, Alexander E., Berezin, Alexander A.
Publicado 2020

Extracellular Vesicles and Thrombogenicity in Atrial Fibrillation

por Berezin, Alexander E., Berezin, Alexander A.
Publicado 2022

Biomarkers in Heart Failure: From Research to Clinical Practice

por Berezin, Alexander E., Berezin, Alexander A.
Publicado 2023

Editorial: Acute heart failure: From bench to bedside

por Berezin, Alexander E., Mozos, Ioana, Lichtenauer, Michael
Publicado 2023

Editorial: Epigenetics in Heart Failure Developing: The Orchestra of Etiology and Comorbidities

por Berezin, Alexander E., Mozos, Ioana, Petrovič, Daniel
Publicado 2022

Emerging Role of Adipocyte Dysfunction in Inducing Heart Failure Among Obese Patients With Prediabetes and Known Diabetes Mellitus

por Berezin, Alexander E., Berezin, Alexander A., Lichtenauer, Michael
Publicado 2020

Myokines and Heart Failure: Challenging Role in Adverse Cardiac Remodeling, Myopathy, and Clinical Outcomes

por Berezin, Alexander E., Berezin, Alexander A., Lichtenauer, Michael
Publicado 2021

Circulating thrombospondin-2 in patients with moderate-to-severe chronic heart failure due to coronary artery disease

por Berezin, Alexander E., Kremzer, Alexander A., Samura, Tatayna A.
Publicado 2016

The signature of circulating microparticles in heart failure patients with metabolic syndrome

por Berezin, Alexander E, Kremzer, Alexander, Berezina, Tatyana, Martovitskaya, Yu
Publicado 2016

Editorial: Prognostication of Heart Failure Evolution: From Circulating Biomarkers to Genetic Risk Predictive Score

por Berezin, Alexander E., Peterlin, Borut, Lichtenauer, Michael, Mozos, Ioana
Publicado 2021

Discriminative Utility of Apelin-to-NT-Pro-Brain Natriuretic Peptide Ratio for Heart Failure with Preserved Ejection Fraction among Type 2 Diabetes Mellitus Patients

por Berezin, Alexander A., Fushtey, Ivan M., Berezin, Alexander E.
Publicado 2022

The Effect of SGLT2 Inhibitor Dapagliflozin on Serum Levels of Apelin in T2DM Patients with Heart Failure

por Berezin, Alexander A., Fushtey, Ivan M., Berezin, Alexander E.
Publicado 2022

Circulating Endothelial-Derived Apoptotic Microparticles in the Patients with Ischemic Symptomatic Chronic Heart Failure: Relevance of Pro-Inflammatory Activation and Outcomes

por Berezin, Alexander E., Kremzer, Alexander A., Samura, Tatayna A., Martovitskaya, Yulia V.
Publicado 2014

Pattern of circulating microparticles in chronic heart failure patients with metabolic syndrome: Relevance to neurohumoral and inflammatory activation

por Berezin, Alexander E., Kremzer, Alexander A., Berezina, Tatyana A., Martovitskaya, Yulia V.
Publicado 2015